Compact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.
Lussier G, Evans AJ, Houston I, Wilsnack A, Russo CM, Vietor R, Bedocs P.
Cureus. 2024 Oct 3;16(10):e70789. doi: 10.7759/cureus.70789. eCollection 2024 Oct.
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Okato A, Utsumi T, Ranieri M, Zheng X, Zhou M, Pereira LD, Chen T, Kita Y, Wu D, Hyun H, Lee H, Gdowski AS, Raupp JD, Clark-Garvey S, Manocha U, Chafitz A, Sherman F, Stephens J, Rose TL, Milowsky MI, Wobker SE, Serody JS, Damrauer JS, Wong KK, Kim WY.
J Clin Invest. 2024 Jan 16;134(2):e169241. doi: 10.1172/JCI169241.
Immune checkpoint inhibitors for urothelial carcinoma.
Kim HS, Seo HK.
Investig Clin Urol. 2018 Sep;59(5):285-296. doi: 10.4111/icu.2018.59.5.285. Epub 2018 Aug 31.
Ultrasound versus Nerve Stimulator Guided Obturator Nerve Block in Patients Undergoing Transurethral Resection of Bladder Tumor.
Baral BK, Poudel PR, Rajbhandari M, Karki AJ, Dhakal GR.
J Nepal Health Res Counc. 2023 Jul 20;20(4):998-1002. doi: 10.33314/jnhrc.v20i4.4523.
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Grande E, Arranz JÁ, De Santis M, Bamias A, Kikuchi E, Del Muro XG, Park SH, De Giorgi U, Alekseev B, Mencinger M, Izumi K, Schutz FA, Puente J, Li JR, O'Donnell PH, Kalebasty AR, Ye D, Mariathasan S, Bene-Tchaleu F, Bernhard S, Lee C, Davis ID, Galsky MD.
Lancet Oncol. 2024 Jan;25(1):29-45. doi: 10.1016/S1470-2045(23)00540-5. Epub 2023 Dec 12.
Celsius Control system.
Badjatia N.
Neurocrit Care. 2004;1(2):201-3. doi: 10.1385/ncc:1:2:201.
Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement.
Gill E, Perks CM.
Int J Mol Sci. 2024 Jan 26;25(3):1557. doi: 10.3390/ijms25031557.
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial.
Abdel-Fattah M, Chapple C, Cooper D, Breeman S, Bell-Gorrod H, Kuppanda P, Guerrero K, Dixon S, Cotterill N, Ward K, Hashim H, Monga A, Brown K, Drake M, Gammie A, Mostafa A, Bruce R, Bell V, Kennedy C, Evans S, MacLennan G, Norrie J; FUTURE Study Group.
Lancet. 2025 Mar 29;405(10484):1057-1068. doi: 10.1016/S0140-6736(24)01886-5. Epub 2025 Mar 22.
Outcome of transurethral resection of bladder tumour under spinal anaesthesia combined with obturator nerve block in Sri Lanka.
Ambegoda M, Shiyanth S, Vidanapathirana S, Kumara S, Gunaratne A, Abeygunasekera A.
Urologia. 2023 Feb;90(1):80-82. doi: 10.1177/03915603221127843. Epub 2022 Nov 3.
Ureteral Stent Discomfort and Its Management.
Fischer KM, Louie M, Mucksavage P.
Curr Urol Rep. 2018 Jun 11;19(8):64. doi: 10.1007/s11934-018-0818-8.
